Pier 88 Investment Partners »

Corcept Therapeutics Incorporated shares owned by Pier 88 Investment Partners

Quarter-by-quarter ownership of Corcept Therapeutics Incorporated (CORT) shares owned by Pier 88 Investment Partners from 13F filings

Historical chart of Pier 88 Investment Partners investment in Corcept Therapeutics Incorporated

Tip: Access up to 7 years of quarterly data

All positions including Corcept Therapeutics Incorporated held by Pier 88 Investment Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Corcept Therapeutics Incorporated by Pier 88 Investment Partners

Quarter filed Position value Share count Share price at filing
2026-06-30 $357k 4.1k 86.95

More positions owned by Pier 88 Investment Partners

Etsy Note 0.250% 6/1 (Principal)
Global Pmts Note 1.500% 3/0 (Principal)
Ppl Cap Fdg Note 2.875% 3/1 (Principal)
Nextera Energy Unit 11/01/2027 (NEE.PT)
Wec Energy Group Note 4.375% 6/0 (Principal)
Bank Of Amer Corp 7.25 Percentage Cnv Pfd L Convertible Preferred (BAC.PL)
Meritage Homes Corp Note 1.750% 5/1 (Principal)
Uber Technologies Note 0.875%12/0 (Principal)
Alphabet Dep Shs Rp1/20 A Added
Wells Fargo & Co Perp Pfd Cnv A Convertible Preferred (WFC.PL)
Shift4 Pmts Note 0.500% 8/0 (Principal)
Euronet Worldwide Note 0.750% 3/1 (Principal)
Southern Note 4.500% 6/1 (Principal)
Hewlett Packard Enterprise C 7.625 Mand Conv Convertible Preferred (HPE.PC)
Alliant Energy Corp Note 3.250% 5/3 Added (Principal)

View all positions for Pier 88 Investment Partners

Top funds holding Corcept Therapeutics Incorporated

BlackRock
Ingalls & Snyder
Renaissance Technologies
Vanguard Portfolio Management
Vanguard Capital Management
Parallel Advisors
FMR
State Street Corporation
AQR Capital Management
Geode Capital Management
First Trust Advisors
Tang Capital Management
UBS Group
Dimensional Fund Advisors
Charles Schwab Investment Management

View all funds holding Corcept Therapeutics Incorporated